Health Care & Life Sciences » Biotechnology | Blueprint Medicines Corp.

Blueprint Medicines Corp. | Key People and Executives

Jeffrey W. Albers
President, Chief Executive Officer & Director
Daniel S. Lynch
Director
Alexis Borisy
Director
Nicholas B. Lydon
Independent Director
Lynn Seely
Independent Director
Lonnel Coats
Independent Director
Mark Alan Goldberg
Independent Director
George D. Demetri
Independent Director
Charles A. Rowland
Independent Director
Jeffrey W. Albers
President, Chief Executive Officer & Director
Michael Landsittel
Vice President-Finance
Marion Dorsch
Chief Scientific Officer
Anthony L. Boral
Chief Medical Officer
Christopher K. Murray
Senior Vice President-Technical Operations
Kathryn Haviland
Chief Business Officer
Daniel S. Lynch
Director
Alexis A. Borisy
Director
Kristin Hodous
Investor Relations Contact
Debbie Durso-Bumpus
Senior Vice President-Human Resources
Tracey L. McCain
Secretary, Chief Legal & Compliance Officer
Nicholas B. Lydon
Independent Director
Lynn Seely
Independent Director
Lonnel Coats
Independent Director
Mark Alan Goldberg
Independent Director
George D. Demetri
Independent Director
Charles A. Rowland
Independent Director

About Blueprint Medicines

View Profile
Address
45 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.blueprintmedicines.com
Updated 07/08/2019
Blueprint Medicines Corp. engages in the research, development, and commercialization of pharmaceutical products. It focuses on medicines to improve the lives of patients with genomically defined cancers and rare diseases. Its portfolio includes BLU-285 and BLU-554 for the treatment of gastrointestinal stromal tumors, systemic mastocytosis, and leukemia.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.